By Staff
Tuesday, October 26, 2021 12:24 AM
LAVAL, QC and ALPHARETTA, Ga.—
Bausch + Lomb, a global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) and
Clearside Biomedical, Inc. (Nasdaq: CLSD) announced Monday that the U.S. Food and Drug Administration (FDA) has approved the drug Xipere (triamcinolone acetonide injectable suspension) for suprachoroidal use for the treatment of macular edema associated with uveitis, a form of eye inflammation. "With this FDA approval, Xipere is the first and only therapy available in the United States that utilizes the suprachoroidal space to treat patients suffering from macular edema associated with uveitis, which is the leading cause of vision loss in people with uveitis," said Joseph C. Papa, chairman and CEO, Bausch Health.
By Staff
Tuesday, October 26, 2021 12:21 AM
SEATTLE, Wash.—
Kubota Vision Inc., a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced that the company received Quality Management System - ISO 13485:2016 certification for the design and development of ophthalmic medical devices.
By Staff
Tuesday, October 26, 2021 12:18 AM
MIAMI—
Bascom Palmer Eye Institute of the University of Miami
Miller School of Medicine announced that Christopher J. Kaler has received a Research to Prevent Blindness (RPB) Medical Student Eye Research Fellowship that will allow him to take a year off from medical school and to devote that time to pursue a research project at Bascom Palmer.
By Staff
Tuesday, October 26, 2021 12:15 AM
NEW YORK—
Vision Monday and
20/20 Magazine are teaming up for the 13th annual EyeVote Readers' Choice Awards to
identify the optical industry’s favorite products and companies this year.
By Staff
Tuesday, October 26, 2021 12:04 AM
Without question the company as a whole performed admirably during the depths of the pandemic, but just as clearly coming together in our respective work locations will allow us to be much better. The pandemic has taken a toll on everyone, everywhere. It is time to move forward with our lives.
By Staff
Monday, October 25, 2021 1:16 PM
A growing number of Americans are concerned about ethical issues and are putting their money where their values are by supporting businesses who share the same concerns, according to the latest Global Consumer Barometer by
Toluna, a technology company specializing in consumer market research. Human rights (51 percent) and environmental issues (51 percent) are the biggest concerns for Americans, followed by poverty (50 percent) and equality/diversity (42 percent), Toluna reported.
By Staff
Monday, October 25, 2021 12:30 AM
NEW YORK—Escalated by the pandemic, consumers and patients are demonstrating their openness to using new technologies to redefine their own sense of wellness and take care of their own health. This is furthering the advent of new remote monitoring systems and wearables which are directly involving the patient in managing care with their doctors. Experts discussed these "Remote Possibilities" during VM's virtual Leadership Summit last week. They talked about how these technology developments can actually strengthen provider relationships with patients and provide healthier outcomes, too.
By Staff
Monday, October 25, 2021 12:24 AM
PINELLAS PARK, Fla.—
Transitions Optical is hosting an online educational event for industry professionals on Tuesday, November 9.
By Staff
Monday, October 25, 2021 12:18 AM
ORLANDO, Fla.—The
American Academy of Optometry Foundation (AAOF) in collaboration with the Beta Sigma Kappa International Optometric Honor Society announced that Kevin Willeford, OD, MS, PhD, FAAO, has been named as the 2021 recipient of the Beta Sigma Kappa (BSK) Research Fellowship. Dr. Willeford is an associate professor at the Nova Southeastern University College of Optometry. This fellowship is designed to provide support for early career optometric and vision science faculty research. It will fund Dr. Willeford’s project, “Do non-strabismic individuals use slow fusional vergence to stabilize binocular alignment across gaze positions?”
By Staff
Friday, October 22, 2021 12:23 PM
NEW YORK—A comprehensive report issued this month by the accounting and management services firm
KPMG takes a closer look at how the current pandemic has impacted the U.S. and global economic landscape. As the firm notes in its report, “Pandemics of the length and scope of the current COVID-19 pandemic can change the economic and geopolitical landscape, literally shape shifting economies in their wake. Data on the shape of economies after pandemics shows higher savings rates, a smaller labor force, lower real interest rates, higher wages, wealth destruction, and lower capital expenditures.”
In addition the report,
“Shape Shifting: How the pandemic is changing the contours of the economy,” finds that in many cases the rate of interest was below the rate of growth after past pandemics.
In addition to population growth patterns, wages and working remotely, KPMG looks into retirement trends and finds some interesting trends that likely will play out for employers for several more years. As the report notes, “In addition to a falling population, retirement rose during the pandemic.” The implications and trends, according to KPMG, are:
• Labor force participation among those over the age of 65 was one of the fastest growing cohorts over the past two decades. The pandemic appears to have reversed this.
• For the approximately 1 million workers below the age of 65 who retired during the pandemic, it is very possible they will return to the labor force if the economic recovery is long and/or strong enough. This would be good news for employers and the outlook for economic growth.
• For around 2.5 million people over the age of 68 who retired during the pandemic, their return is unlikely. This poses a structural drag on consumption and in turn inflation in the years ahead.
By Staff
Friday, October 22, 2021 12:33 AM
NEW YORK—As the Oct. 20 virtual VM Leadership Summit kicked off on Wednesday afternoon, two expert speakers talked about how the pandemic has put patients' trust to the test, and more importantly, how providers can tackle the issue of misinformation and help counter the formidable challenge of rebuilding that trust. In a session titled Rebuilding Trust, Dr. John Whyte, chief medical officer for
WebMD and Jennifer Hauser, head of Edelman’s
Wellness 360 business unit, shared views about how today’s eyecare professionals can build trust with their patients.
By Staff
Friday, October 22, 2021 12:30 AM
NORWALK, Conn.—Returning to a live, in-person format for 2022,
IDOC’s annual national conference, The Connection, is scheduled for Feb. 24-26 in Orlando, Fla.
By Staff
Friday, October 22, 2021 12:27 AM
DALLAS—
Essilor announces the creation of a state-of-the-art digital event platform, the Essilor Vision Care Center, and opens registration for the center’s inaugural event: the Global Varilux Summit.
By Staff
Friday, October 22, 2021 12:24 AM
DULUTH, Ga.—
National Vision, Inc. (NASDAQ: EYE) released its first Corporate Responsibility Report, titled
A World Worth Seeing as part of its ongoing efforts to increase transparency in its environmental, social and governance (ESG) activities.
By Staff
Friday, October 22, 2021 12:21 AM
SEATTLE, BOSTON and TOKYO—
Aurion Biotech, which is developing novel treatments for preventing blindness, has formed a medical advisory board composed of eminent ophthalmologists. The board will collaborate with the company’s executive team in clinical development, and is chaired by Edward Holland, MD, who was recently appointed as Aurion Biotech's chief medical advisor. “The doctors on this board are among the best in our field,” said Dr. Holland. “Their expertise, commitment to, and enthusiasm for Aurion Biotech’s cell therapy speak volumes about the transformational potential of this treatment to cure blindness resulting from corneal endothelial disease. I welcome their contributions. It’s a privilege to work closely with each of them.”